NanoViricides Inc

NNVCAMEX · USD
1.42USD0.00 (+1.43%)
122

NanoViricides Inc (NNVC) Option Chain

As of September 18, 2026, NanoViricides Inc is trading at $1.42, a +1.43% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 195.0%. IV Rank is 20%.

Read more

Tracking the NNVC option chain helps you see every strike and expiry on NanoViricides Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. NanoViricides Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of NNVC options activity at a glance. Use our scanner to monitor the NNVC option chain in real time and filter for the NNVC options trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For NNVC stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the NNVC option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where NNVC stock options are being actively traded and where they are not.

NanoViricides, Inc., a nano-biopharmaceutical research and development company, discovers, develops, and commercializes drugs for the treatment of viral infections. The company develops Human Coronavirus Program for COVID-19 seasonal coronavirus affliction; HerpeCide Dermal Topical and Eye Drops for the treatment of shingles, PHN, chickenpox, herpes, recurrent herpes labialis, genital herpes, and ocular herpes keratitis; and HerpeCide IntraOcular Injection for viral acute retinal necrosis The company also develops FluCide Broad-Spectrum Anti-Influenza nanoviricide, which is injectable for hospitalized patients and oral for outpatients; Nanoviricide eye drops for viral diseases of the external eye; DengueCide for treatment of various types of Dengue viruses; and HIVCide, an escape-resistant anti-HIV nanoviricide.

In addition, it develops other nanoviricides drug projects for treatment of different viruses and indications; and HerpeCide program expansion drug projects for different herpes viruses for different indications. NanoViricides, Inc. was founded in 2005 and is based in Shelton, Connecticut.

Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls NanoViricides Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen NNVC options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of NNVC stock options — let the full option chain come to you, pre-filtered and ready to trade.

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV percentile25.40% Subdued
  • Market cap (M$)36
  • 52 weeks high-36.32%
  • 52 weeks low67.06%
  • Analyst recommendationStrong Buy
    1.00
  • Target price$6.00
    322.54% above the current stock price
  • Dividend
  • Payout ratio
  • Earnings date2026-10-05
  • P/E
  • Future P/E2.84
  • EPS (ttm)-0.44
  • EPS growth next 5 years

As of September 18, 2026

2026-10-16
5 strikes
Default
CALLsPUTs
Prob. OTM %Open InterestVolumeExtrinsic ValueIntrinsic ValueBidAskStrikeMoneyness %BidAskIntrinsic ValueExtrinsic ValueVolumeOpen InterestProb. OTM %
90.713520.100.000.102.50+76.060.751.501.080.04039.29
99.57100.100.000.105.00+252.113.004.203.580.02000.43
99.96003.700.003.707.50+428.175.406.906.080.07000.04

As of September 18, 2026

Scan the full option chain in one place

Browse the full NNVC option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.

Start your 14-day free trial